These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 27603596

  • 1. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X, Meng Y, Sheng X, Guan Y, Zhang F, Han Z, Kang Y, Tai G, Zhou Y, Cheng H.
    Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC, Kuan CP, Lin JY, Lai JS, Ho TF.
    Chem Res Toxicol; 2015 Aug 17; 28(8):1574-83. PubMed ID: 26203587
    [Abstract] [Full Text] [Related]

  • 6. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
    Gupta SC, Francis SK, Nair MS, Mo YY, Aggarwal BB.
    J Biol Chem; 2013 Nov 08; 288(45):32343-32356. PubMed ID: 24078627
    [Abstract] [Full Text] [Related]

  • 7. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L, Zongyuan Y, Cheng G, Lingyun Z, Guilian Y, Wei G.
    Cancer Sci; 2014 May 08; 105(5):520-7. PubMed ID: 24612139
    [Abstract] [Full Text] [Related]

  • 8. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells.
    Wu W, Yang Y, Deng G, Ma L, Wei G, Zheng G, Han X, He D, Zhao Y, He J, Cai Z, Yu R.
    Mol Carcinog; 2017 Oct 08; 56(10):2190-2199. PubMed ID: 28467689
    [Abstract] [Full Text] [Related]

  • 9. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB.
    J Biol Chem; 2010 Nov 12; 285(46):35418-27. PubMed ID: 20837473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.
    Prasad S, Yadav VR, Ravindran J, Aggarwal BB.
    Cancer Res; 2011 Jan 15; 71(2):538-49. PubMed ID: 21127198
    [Abstract] [Full Text] [Related]

  • 12. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
    Zhao Y, Tian B, Wang Y, Ding H.
    Med Sci Monit; 2017 Oct 26; 23():5096-5105. PubMed ID: 29070784
    [Abstract] [Full Text] [Related]

  • 13. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
    Mol Cancer Ther; 2011 Oct 26; 10(10):1969-81. PubMed ID: 21817114
    [Abstract] [Full Text] [Related]

  • 14. Licochalcone D exhibits cytotoxicity in breast cancer cells and enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through upregulation of death receptor 5.
    Zhang Y, Wang L, Dong C, Zhuang Y, Hao G, Wang F.
    J Biochem Mol Toxicol; 2024 Jul 26; 38(7):e23757. PubMed ID: 38937960
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.
    FEBS J; 2008 Apr 26; 275(8):1925-36. PubMed ID: 18341587
    [Abstract] [Full Text] [Related]

  • 16. Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway.
    Trivedi R, Maurya R, Mishra DP.
    Cell Death Dis; 2014 Oct 16; 5(10):e1465. PubMed ID: 25321472
    [Abstract] [Full Text] [Related]

  • 17. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.
    Qiao X, Wang X, Shang Y, Li Y, Chen SZ.
    Cancer Commun (Lond); 2018 Jul 03; 38(1):43. PubMed ID: 29970185
    [Abstract] [Full Text] [Related]

  • 18. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
    Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ.
    J Cell Biochem; 2019 Jan 03; 120(1):928-939. PubMed ID: 30160785
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY, Hong M, Heo SH, Park S, Kwon TK, Sung YH, Oh Y, Lee S, Yi GS, Kim I.
    Mol Carcinog; 2018 Nov 03; 57(11):1492-1506. PubMed ID: 29964331
    [Abstract] [Full Text] [Related]

  • 20. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
    Fei HR, Yuan C, Wang GL, Zhao Y, Li ZJ, Du X, Wang FZ.
    Phytomedicine; 2019 Sep 03; 62():152950. PubMed ID: 31102888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.